Sept. 22, 2026 — Following transcatheter aortic valve implantation (TAVI), disturbances in the heart’s electrical conduction system can make a pacemaker necessary. A recent study now shows that the ...
Interventional Cardiology
-
-
The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a series of new rules from the Centers for Medicare & Medicaid Services (CMS). Earlier ...
-
Aug. 28, 2026 — Royal Philips and Imricor Medical Systems have announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines ...
-
June 11, 2026— Penumbra, Inc. has received U.S. Food and Drug Administration (FDA) clearance for Thunderbolt, expanding its computer assisted vacuum thrombectomy (CAVT) technology to address acute ...
Oct. 12, 2026 — Endovascular Engineering (E2) has announced that the U.S. Food and Drug Administration (FDA) has granted ...
October 13, 2026
Sept. 22, 2026 — Following transcatheter aortic valve implantation (TAVI), disturbances in the heart’s electrical ...
September 25, 2026
Sept. 17, 2026 — Conavi Medical Corp. has announced the publication of a peer-reviewed case report highlighting the ...
September 22, 2026Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026
Sept. 15, 2026 — The Food & Drug Administration has approved Abbott’s AVEIR VR Mini Ventricular leadless pacemaker (LP) ...
September 16, 2026
Sept. 14, 2026 — Interventional Medical Device Solutions (IMDS), has announced the U.S. launch of NHanceIT, an over-the ...
September 15, 2026
Feature | Heart Failure | Kyle Hardner
The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a ...
September 11, 2026Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026
Aug. 28, 2026 — Royal Philips and Imricor Medical Systems have announced a new Interventional MR (iMR) lab solution for ...
September 01, 2026
Aug. 26, 2026 – The Cardiovascular Research Foundation (CRF) announced the late-breaking clinical trials and science sel ...
August 31, 2026
Aug. 20, 2026 — Bayer has announced that 11 oral presentations across its cardiovascular, kidney, and secondary stroke ...
August 20, 2026
Aug. 4, 2026 — Abbott has completed enrollment in its TECTONIC coronary artery disease (CAD) Intravascular Lithotripsy ...
August 06, 2026
July 9, 2026 — On July 9, Stereotaxis announced that it has completed its previously announced acquisition of Robocath ...
July 10, 2026
June 17, 2026 — VahatiCor, Inc., a medtech company developing interventional therapies for coronary microvascular ...
June 22, 2026
June 15, 2006 — Penumbra, Inc. has secured the CE Mark in Europe for Thunderbolt, further laying the groundwork for ...
June 15, 2026
June 11, 2026— Penumbra, Inc. has received U.S. Food and Drug Administration (FDA) clearance for Thunderbolt, expanding ...
June 12, 2026
May 11, 2026 — In May, Robocath announced the completion of patient enrollment in the FIH (First-In-Human) clinical ...
June 04, 2026